Rimexolone is indicated for the treatment of postoperative inflammation following ocular surgery, for the treatment of anterior uveitis, and for the treatment of corticosteroid responsive inflammation of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe. The inflammation should be of a noninfectious nature. In more serious cases, and if the posterior part of the globe is affected, subconjunctival injection or systemic treatment is recommended.
For this indication, competent medicine agencies globally authorize below treatments:
Ophthalmic
4 - 4 {drops}
From 1 To 1 {drops} 4 time(s) per day every day
Apply one drop of rimexolone into the conjunctival sac of the affected eye four times daily beginning 24 hours after surgery and continuing throughout the first 2 weeks of the postoperative period. There are no clinical data on the use of rimexolone immediately after surgery.